Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) shareholders won’t be pleased to see that the share price has had a very rough month, dropping 29% and undoing the prior period’s positive performance. Of course, over the longer-term many would still wish they owned shares as the stock’s price has soared 143% in the last twelve months.
Even after such a large drop in price, you could still be forgiven for feeling indifferent about Shanghai HeartCare Medical Technology’s P/S ratio of 5.1x, since the median price-to-sales (or “P/S”) ratio for the Medical Equipment industry in Hong Kong is also close to 5.5x. Although, it’s not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
